Abstract
Technetium (99mTc) hexamethyl propylene amine oxime (HM-PAO) was injected into the internal carotid artery in ten epileptic patients after the end of amobarbital speech-memory tests. The cerebral perfusion as visualized from SPET was compared to cerebral angiographies, which showed unilateral filling of intracranial vessels in seven patients. SPET revealed cross-flow between the hemispheres in four of these seven patients. In three patients in whom the angiograms had shown bilateral contrast filling, SPET showed cross-flow in only two. It is concluded that99mTc-HM-PAO SPET examinations provide valuable information for correct interpretation of amobarbital tests on cognitive hemisphere functions. The SPET technique may help to explain atypical speech and memory responses caused by unusual intracranial vascularization.
Similar content being viewed by others
References
Aasly J, Silfvenius H, Zetterlund B (1989) Barbiturate effects on EEG abnormality in complex partial epilepsy. J Neurol 236:15–20
Biersack HJ, Linke D, Brassel LF, Reichmann K, Kurthen M, Durwen HF, Reuter BM, Wappenschmidt J, Stefan H (1987 a) Technetium-99m HM-PAO brain SPECT in epileptic patients before and during unilateral hemispheric anesthesia (Wada Test): report of three cases. J Nucl Med 28:1763–1767
Biersack HJ, Stefan H, Reichmann K, Linke D, Kurthen M, Kropp J, Penin H (1987b) HM-PAO brain SPECT and epilepsy. Nucl Med Commun 8:513–518
Bogousslavsky J, Regli F, Uske A (1986) Thalamic infarct: clinical syndromes, etiology, and prognosis. Neurology 49:837–848
Bruyn RPM (1989) Thalamic aphasia. J Neurol 236:21–25
Buell U, Braun H, Ferbert A, Stirner H, Weiller C, Ringelstein EB (1988) Combined SPECT imaging of regional cerebral blood flow (99mTc-hexamethyl-propyl-encamine oxime, HMPAO) and blood volume (99mTc-RBC) to assess regional cerebral perfusion reserve in patients with cerebrovascular disease. Nuklearmedizin 27:51–56
Cramon DY von, Hebel N, Schuri U (1985) A contribution to the anatomical basis of thalamic amnesia. Brain 108:993–1008
De Roo M, Mortelmans L, Vevos P, Verbruggen A, Wilms G, Carton H, Wils V (1989) Clinical experience with99mTc-HMPAO high resolution SPECT of the brain in patients with cerebrovascular accidents. Eur J Nucl Med 15:9–15
Ell PJ, Hocknell JML, Jarritt PH, Cullum I, Lui D. Campos-Costa D, Nowotnik DP, Pickett RD, Canning LR, Neirinckx RD (1985) A99mTc-labelled radiotracer for the investigation of cerebral vascular disease. Nucl Med Commun 6:437–441
Engel J Jr, Kuhl DE, Phelps ME, Rausch R, Nuwer M (1983) Local cerebral metabolism during partial seizures. Neurology 33:400–413
Holm S, Andersen AR, Vorstrup S, Lassen NA, Paulson OB, Holmes RA (1985) Dynamic SPECT of the brain using a lipophilic Technetium-99m complex, PnAO. J Nucl Med 26:1129–1134
Jack CR, Nichols DA, Sharbrough FW, March WR, Petersen R (1988) Selective posterior cerebral artery amytal test for evaluating memory function before surgery for temporal lobe seizure. Radiology 168:787–793
Lang W, Podreka I, Suess E, Müller C, Zeitlhofer J, Deecke L (1988) Single photon emission computerized tomography during and between seizures. J Neurol 335:277–284
Langen KJ, Herzog H, Rota E, Roosen N, Wieler H, Kiwit J, Kuwert T, Storch-Becker A, Feinendegen L (1987) Tomographic studies of rCBF with99mTc-HM-PAO SPECT in comparison with PET in patients with primary brain tumors. Neurosurg Rev 10:23–24
Lee BI, Markand ON, Wellman HN, Siddiqui AR, Park HM, Mock B, Worth RM, Edwards MK, Krepshaw J (1988) HIPDM-SPECT in patients with medically intractable complex partial seizures. Arch Neurol 45:397–402
Leonard JP, Nowotnik DP, Neirinckx RD (1986) Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT — a comparison with iodine-123 HIPDM. J Nucl Mod Dec 27:1819–1823
Milner B, Branch C, Rasmussen T (1966) Evidence for bilateral speech representation in some non-right-handers. Trans Am Neurol Assoc 91:306–308
Nickel O, Nägele-Wöhrle B, Ulrich P, Eissner D, Roesler A, Grimm W, Hahn K (1989) RCBF-quantification with99mTc-HMPAO SPECT: theory and first results. Eur J Nucl Med 15:1–8
Percheron G (1973) The anatomy of the arterial supply of the human thalamus and its use for the interpretation of the thalamic vascular pathology. Z Neurol 205:1–13
Podreka I, Suess E, Goldenberg G, Steiner M, Brücke T, Müller C, Lang W, Neirinckx RD, Deecke L (1987) Initial experience with Technetium-99m HM-PAO brain SPECT. J Nucl Med 28:1657–1666
Rasmussen T, Milner B (1975) Clinical and surgical studies of the cerebral speech areas in man. In: Zülch KR, Creutzfeldt O, Galbraith GC (eds) Cerebral localization. Springer, New York Berlin Heidelberg, pp 238–257
Rausch R (1987) Psychological evaluation of epileptic patients. In: Engel Jr (ed) Surgical treatment of the epilepsies. Raven Press, New York, pp 181–196
Spreafico G, Cammelli F. Gadola G, Nicola G, Zancaner F, Tonnarelli G, Sala E, Freschi R (1987) Initial experience with SPECT of the brain using99mTc-hexamethyl propylene amine oxime (99mTe-HM-PAO). Eur J Nucl Med 12:557–559
Stefan H, Kuhnen C, Biersack HJ, Reichmann K (1987) Initial experience with 99m Tc-hexamethyl-propylene amine oxime (HM-PAO) single photon emission computed tomography (SPECT) in patients with focal epilepsy. Epilepsy Res 1:134–138
Tuszynski MH, Petito CK (1988) Ischemic thalamic aphasia with pathologic confirmation. Neurology 38:800–802
Wada J, Rasmussen T (1960) Intracarotid injection of sodium amytal for the lateralization of cerebral speech dominance. Experimental and clinical observations. J Neurosurg 17:266–282
Wyler AR, Ojemann GA, Lettich E, Ward AA (1984) Subdural strip electrodes for localizing epileptogenic foci. J Neurosurg 60:1195–1200
Zola-Morgan S, Squire LR (1985) Medial temporal lesions in monkeys impair memory in a variety of tasks sensitive to human amnesia. Behav Neurosci 99:22–34
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hietala, SO., Silfvenius, H., Aasly, J. et al. Brain perfusion with intracarotid injection of99mTc-HM-PAO in partial epilepsy during amobarbital testing. Eur J Nucl Med 16, 683–687 (1990). https://doi.org/10.1007/BF00998169
Issue Date:
DOI: https://doi.org/10.1007/BF00998169